Moderna stock tanks on COVID vaccine delivery slowdown Due to the delays and prioritization of low-income countries, Moderna anticipates fiscal year 2021 product sales between $15B and $18B, down from previous guidance of $20 billion. https://ift.tt/tlaYvXi https://ift.tt/p8q2cHW Markets November 4, 2021 at 07:59PM
إرسال تعليق